HubXchange's US West Coast CNS Therapeutics Meeting - 29th September

With preclinical/clinical transition being the largest failure risk in CNS therapeutics development, Transpharmation will be revealing new scientific development work at the 2022 HubXchange’s CNS Therapeutics West Coast round table meeting, where senior drug developers from pharma and biotech share experiences and discuss the future research landscape. Chief Scientific Officer Guy Higgins, PhD, is a keynote speaker this year and will be presenting 'An application of a versatile rodent operant platform to drug discovery today.'

We will make this work available on our website if you are unable to attend. 

Read about hubXchange.

HubXchange's US West Coast CNS Therapeutics Meeting - 29th September